Half-year report 2024   Half-year report 2024

New Post Public Reply Private Reply Replies (0) Message Board
News
46
Half-year report 2024

 

Half-year report 2024

January - June 2024

Continued development and expansion of Virtune’s product offering and distribution platforms First half of the year, 1 January – 30 June 2024 in brief • Net sales amounted to 5 408 KSEK (19 KSEK). • Operating profit before depreciation (EBITDA) amounted to - 8 290 KSEK (- 6 858 KSEK). • The operating profit (EBIT) amounted to - 8 522 KSEK (- 6 929 KSEK). • The net profit amounted to - 9 118 KSEK (- 6 965 KSEK). • The cash flow from current operations amounted to - 11 980 KSEK (- 6 506 KSEK). • AUM end of the period amounted to 809 MSEK (9 MSEK). Events during the period · Virtune AB (Publ) launched Virtune Staked Polkadot ETP and Virtune Arbitrum ETP on Nasdaq Stockholm in January. · Virtune AB (Publ) renewed its EU Base Prospectus for the issue program of crypto ETPs according to EU regulations and published the Base Prospectus for 2024. · Virtune AB (Publ) launched Virtune Staked Solana ETP and Virtune Staked Polygon ETP on Nasdaq Stockholm in April. · The AGM was held and a new board was elected, represented by Erik Fischbeck as the new chairman, together with Laurent Kssis, Fredrik Djavidi and co-founder Christopher Kock to complete the new board. · Virtune AB ( Publ ) launched Virtune Staked Cardano ETP on Nasdaq Stockholm in May 2024. · Virtune enters into an agreement with an additional staking provider, Figment Inc. · Virtune and Kvarn Capital have formed a strategic partnership to increase crypto adoption in the Nordics and beyond. Events after the period · Virtune AB (Publ) launched Virtune Avalanche ETP on Nasdaq Stockholm in July 2024. · Virtune AB (Publ) launched Virtune XRP ETP on Nasdaq Stockholm in July 2024. CEO statement

Continued development and expansion of Virtune’s product offering and distribution platforms

It has been just over a year since we entered the Swedish financial market with the launch of the Nordic region's first crypto index ETP. Since then, Virtune has achieved many significant milestones, leaving behind an intense and rewarding half-year. The first half of 2024 has been a successful period where the company's main focus has been on expanding our product portfolio and strengthening our presence and brand in the Nordic market. In H1, we made significant progress in the Swedish financial market by signing an agreement with one of Sweden's largest advisory platforms, which becomes the first advisory platform in Sweden to enable advice for Crypto-ETPs. During this period, we experienced rapid growth in our assets under management, growing from about 200 MSEK at the end of December 2023 to about 800 MSEK at the end of the first half of 2024. During the first half of the year, we renewed our base prospectus, which was approved by the Financial Supervisory Authority on April 5, 2024. We also elected a new board of directors aimed at best preparing and structuring the company for future growth and expansion. This means that we have secured expertise in all the areas that will be critical for Virtune to succeed in its upcoming growth journey. We have also expanded the operational team with an operations manager and a software developer, which will enable us to handle more products, markets, and distribution platforms. This contributes to us being well-prepared for strong growth going forward. Our vision is to bridge the gap between the traditional financial market and the crypto market by being a regulated actor that stands for education and transparency. We believe that our strong corporate governance, risk management, transparency, and educational role in the market will help us achieve our vision of becoming the leading asset manager within crypto in the Nordics. With this position, we are well-prepared to meet the increasing demand for crypto investments through exchange-traded products from both institutional and private investors. Now that the American SEC has approved Bitcoin ETFs in January and Ethereum ETFs in May, we consider these approvals as important milestones and further recognition of crypto as an asset class. During Q2, the Bitcoin halving also occurred, an event that halves the rate at which new Bitcoins are created, which has historically led to market rallies. With the MiCA regulation (Markets in Crypto Assets) in the EU, increased acceptance for crypto in the USA through ETFs, the UK's recent approval of crypto-ETPs, Hong Kong's approval of Bitcoin and Ethereum ETFs, the long-term fundamentals for the coming years look very strong. Best regards,

Stockholm on 16th of August 2024,

Christopher Kock, CEO & Board Member of Virtune AB (Publ) For more information, please contact:

Christopher Kock, CEO & Board Member Mobile: +46 70 073 45 64 Email address: christopher@virtune.com About Virtune AB (Publ)

Virtune with its headquarters in Stockholm is a fully regulated Swedish digital asset manager and issuer of crypto exchange traded products on regulated European exchanges.

With regulatory compliance, strategic collaborations with industry leaders and our proficient team, we empower investors on a global level to access innovative and sophisticated investment products that are aligned with the evolving landscape of the global crypto market. See the attached PDF for the full half-year report.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 71

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 92

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
STVN's GLP-1 Fumble Sparks Shareholder Scrutiny

Updated Category News Views 35

The Storm Hits Stevanato: GLP-1 Blues Well, ain't this a fine pickle for Stevanato Group S.p.A. (NYSE:STVN). November 3, 2026, turned into quite the ride for those holding STVN shares. A tough third-quarter report dropped like a ton of bricks, driving the shares down after they coughed up a lower outlook for GLP-1 volumes in 2027. If you've been in the game long enough,...

Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds

Updated Category News Views 17

A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...

Continue Reading
ROBOTWORLD 2026: AI Reshapes Industrial Horizons

Updated Category News Views 48

A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 94

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 0

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 101

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Compass Faces Securities Fraud Suit: Deadline Looms

Updated Category News Views 45

Compass's Legal Rumble: Shareholders Take Note You know there’s trouble when a firm’s every effort at glassy-eyed optimism is slapped with a lawsuit. We've seen this song and dance far too often, and now Compass, Inc. (NYSE: COMP) takes center stage. Schall, Brown & Schwartz LLP is rallying the troops for a knock-down-drag-out class action lawsuit, accusing Compass of...

Continue Reading
s of Cautious Optimism - Continue Reading" aria-label="Continue reading: Farmer Sentiment Rises, Hints of Cautious Optimism"> Continue Reading
More News Articles

Top 5 Most Recently Viewed Articles

Analyzing Meta Platforms: A Deep Dive into Finances and Growth

Updated Category News Views 624

Examining Meta Platforms Against Industry Rivals In today’s fast-paced and competitive business environment, investors and industry analysts must perform thorough evaluations of companies. This article explores Meta Platforms (NASDAQ: META) in comparison to its key competitors within the Interactive Media & Services space. By analyzing significant financial metrics,...

Continue Reading
Key Stocks to Monitor for Imminent Market Movements

Updated Category News Views 241

Stocks Captivating Investors Ahead of Market Open As U.S. stock futures exhibit a downward trend this Tuesday morning, several companies are poised to attract the attention of investors looking for opportunities in the market. Below, we explore key stocks including Home Depot Inc., Medtronic PLC, and others making headlines today. Home Depot's Earnings Forecast Home Depot...

Continue Reading
CollPlant Unveils Q2 2025 Financial Results and Growth Plans

Updated Category News Views 139

CollPlant Unveils Q2 2025 Financial Results and Growth Plans CollPlant Biotechnologies, a pioneering name in regenerative medicine, has recently disclosed its financial results for the second quarter of 2025, showcasing significant progress and updates on its corporate initiatives. - Sales for rhCollagen and bioinks are set for a boost following enhancements in leadership...

Continue Reading
Virtual Nursing Growth: Insights Into Provider Adoption Trends

Updated Category News Views 179

Survey Reveals Virtual Nursing Adoption Trends A recent report highlights the evolving landscape of virtual nursing, emphasizing the significant strides made by healthcare providers in enhancing care delivery. Despite these advancements, many organizations remain at the initial stages of implementation. The State of Inpatient Virtual Care The findings from this...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 109

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading